Pacific Bio CA (PACB)
$1.13
0.00 (0.00%)
PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q2 2024
PACB stock results show that Pacific Biosciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Previous Close
$1.18
Market Cap
351.47M
PE Ratio
-1.05
EPS
-1.075
Volume (Avg. Vol.)
5.77M
Day's Range
$1.12 - $1.22
52-Week Range
$1.08 - $3.70
Dividend & Yield
N/A (N/A)

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?